Article
The Welander TIA1 mutation dedifferentiates insulin-producing cells: Reversal by a GLP-1 receptor agonist.
The Journal of biological chemistry - 1 Apr 2026
Zhao Tongjian, Cen Jing, Wang Xuan, Yang Mingyu, Lau Joey, Tengholm Anders, Sjöholm Åke, Welsh Nils
Abstract excerpt
The RNA-binding proteins TIAR and TIA1 have been reported to affect beta-cell insulin production and viability. The missense E384K TIA1 autosomal dominant mutation is known to cause Welander distal myopathy. This study aimed to study the effects of the TIA1 E384K mutation in human insulin-producing EndoC-βH1 cells. The prime editing technique was used to generate EndoC-βH1 cell clones with the homozygous E384K...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
